{
    "items": "94",
    "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
    "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
    "feed": [
        {
            "title": "Why Shares of Structure Therapeutics Are Soaring on Friday",
            "url": "https://www.fool.com/investing/2023/09/29/why-shares-of-structure-therapeutics-are-soaring-o/",
            "time_published": "20230929T165023",
            "authors": [
                "Jim Halley"
            ],
            "summary": "The company reported positive results from an early-stage clinical trial for its weight-loss therapy candidate.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.197045,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.059066",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.541149",
                    "ticker_sentiment_score": "0.319855",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.146916",
                    "ticker_sentiment_score": "0.059066",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "A New Contender Enters The Weight-Loss Ring. Shares Rocket 66%.",
            "url": "https://www.investors.com/news/technology/biotech-stock-structure-catapults-as-it-takes-on-novo-lilly-in-weight-loss-drugs/",
            "time_published": "20230929T133400",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "Biotech Stock Structure Catapults As It Takes On Novo, Lilly In ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/03/stock-pharmaceutical-6-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.038367,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.320974",
                    "ticker_sentiment_score": "0.267396",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GPCR",
                    "relevance_score": "0.320974",
                    "ticker_sentiment_score": "-0.06137",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.320974",
                    "ticker_sentiment_score": "0.267396",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs",
            "url": "https://www.zacks.com/stock/news/2157714/pharma-stock-roundup-fda-and-ema-regulatory-updates-for-abbv-lly-sny-mrks-drugs",
            "time_published": "20230929T132800",
            "authors": [
                "Kinjel Shah"
            ],
            "summary": "The European Commission approves AbbVie's (ABBV) Tepkinly (epcoritamab) for DLBCL. FDA approves Lilly's (LLY) Jardiance for chronic kidney disease.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/952.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                }
            ],
            "overall_sentiment_score": 0.215184,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.116536",
                    "ticker_sentiment_score": "0.100453",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.038969",
                    "ticker_sentiment_score": "-0.121201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.077845",
                    "ticker_sentiment_score": "0.114096",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.038969",
                    "ticker_sentiment_score": "-0.116285",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly, Former Employee Settle Lawsuit Concerning Manufacturing Dispute - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34997436/eli-lilly-former-employee-settle-lawsuit-concerning-manufacturing-dispute",
            "time_published": "20230929T121515",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY has settled a lawsuit filed by a former employee, Amrit Mula, who alleged that she was wrongfully terminated after raising concerns about manufacturing practices and data falsification related to the diabetes drug Trulicity.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/29/lly.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": -0.213343,
            "overall_sentiment_label": "Somewhat-Bearish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.595343",
                    "ticker_sentiment_score": "-0.1729",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle",
            "url": "https://www.investors.com/news/technology/abbott-stock-surges-after-spelling-out-bull-case-in-battle-with-weight-loss-drugs/",
            "time_published": "20230928T162200",
            "authors": [
                "Investor's Business Daily",
                "ALLISON GATLIN"
            ],
            "summary": "Abbott Stock Surges After Spelling Our Bull Case In Battle With ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2019/10/stock-Abbott-05-shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                }
            ],
            "overall_sentiment_score": 0.259839,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "EVR",
                    "relevance_score": "0.082393",
                    "ticker_sentiment_score": "0.067297",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.163909",
                    "ticker_sentiment_score": "0.272253",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABT",
                    "relevance_score": "0.163909",
                    "ticker_sentiment_score": "0.052129",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.395012",
                    "ticker_sentiment_score": "0.090731",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Despite Being Costly, Ozempic, Wegovy Prescriptions Surge 300% Over Three Years - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34970749/despite-being-costly-ozempic-wegovy-prescriptions-surge-300-over-three-years",
            "time_published": "20230928T122231",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "An analytics firm Trilliant Health analysis revealed a significant surge in prescriptions for diabetes and obesity drugs like Ozempic and Wegovy during the last quarter of 2022. The quarterly prescriptions for these drugs have witnessed an astounding 300% increase from early 2020 to the end of 2022.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/28/ozempic.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.222672,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.416844",
                    "ticker_sentiment_score": "0.067278",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.535653",
                    "ticker_sentiment_score": "0.519825",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Nektar  ( NKTR ) , Cellular Biomedicine Join for Lung Cancer Studies",
            "url": "https://www.zacks.com/stock/news/2156973/nektar-nktr-cellular-biomedicine-join-for-lung-cancer-studies",
            "time_published": "20230928T115800",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Nektar (NKTR) enters into a deal with Cellular Biomedicine Group to develop NKTR-255 in combination with C-TIL05 to treat advanced NSCLC.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.007194,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.368773",
                    "ticker_sentiment_score": "-0.05567",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.127119",
                    "ticker_sentiment_score": "0.066031",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANVS",
                    "relevance_score": "0.251032",
                    "ticker_sentiment_score": "-0.056004",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKTR",
                    "relevance_score": "0.528475",
                    "ticker_sentiment_score": "0.186757",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Popular Weight Loss Drugs Ozempic and Wegovy Alert: FDA Adds Intestinal Blockage Warning - Novo Nordisk  ( NYSE:NVO ) , Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34953403/popular-weight-loss-drugs-ozempic-and-wegovy-alert-fda-adds-intestinal-blockage-warning",
            "time_published": "20230927T155250",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "In a significant development, the FDA has updated the labeling for Novo Nordisk A/S's NVO Ozempic, a diabetes drug known for its weight loss side effect, to include warnings about reports of blocked intestines following its use.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/27/warnings-image_by_openicons_from_pixabay.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.127534,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.433523",
                    "ticker_sentiment_score": "-0.118661",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.660632",
                    "ticker_sentiment_score": "-0.181153",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Top Stories Wednesday, Sep 27: Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds - Alibaba Gr Holding  ( NYSE:BABA ) ",
            "url": "https://www.benzinga.com/news/23/09/34949379/apple-defends-its-19b-google-search-deal-hollywoods-writers-secure-credit-for-ai-training-chinas-amb",
            "time_published": "20230927T134747",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Alibaba Group Holding Limited BABA stock is trading higher Wednesday as the company's logistics arm Cainiao Smart Logistics Network Ltd filed for its Hong Kong initial public offering on Tuesday. The first-time share sale could fetch a minimum of $1 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/27/google_search_iphone.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.148277,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BABA",
                    "relevance_score": "0.111144",
                    "ticker_sentiment_score": "0.095986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NFLX",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.159668",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TGT",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.077628",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.184176",
                    "ticker_sentiment_score": "0.084378",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.111144",
                    "ticker_sentiment_score": "0.025411",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PARA",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.159668",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.07364",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TRI",
                    "relevance_score": "0.111144",
                    "ticker_sentiment_score": "0.053298",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSM",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SSNLF",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "-0.051384",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMG",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.273503",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PAYX",
                    "relevance_score": "0.111144",
                    "ticker_sentiment_score": "0.070338",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QCOM",
                    "relevance_score": "0.147818",
                    "ticker_sentiment_score": "-0.038811",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.147818",
                    "ticker_sentiment_score": "0.067619",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.083661",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.07423",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Stock Moves -0.41%: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2155702/eli-lilly-lly-stock-moves--041-what-you-should-know",
            "time_published": "20230926T214518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) closed the most recent trading day at $550.01, moving -0.41% from the previous trading session.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default275.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.111179,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.608634",
                    "ticker_sentiment_score": "0.226675",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "2 Magnificent Dividend Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2023/09/26/2-magnificent-dividend-stocks-to-buy-right-now/",
            "time_published": "20230926T170000",
            "authors": [
                "George Budwell"
            ],
            "summary": "These two expensive dividend stocks are worth the price of admission.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F748811%2Ftime-to-buy.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                }
            ],
            "overall_sentiment_score": 0.356891,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.318897",
                    "ticker_sentiment_score": "0.337037",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.257668",
                    "ticker_sentiment_score": "0.442075",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34916986/check-out-what-whales-are-doing-with-lly",
            "time_published": "20230926T161540",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 13 strange trades. If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.099287,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.831658",
                    "ticker_sentiment_score": "0.269075",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.12165",
                    "ticker_sentiment_score": "-0.132256",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity For September 25 - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34874544/eli-lilly-unusual-options-activity-for-september-25",
            "time_published": "20230925T173109",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 19 strange trades. If we consider the specifics of each trade, it is accurate to state that 52% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.134794,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.767534",
                    "ticker_sentiment_score": "0.156028",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.118647",
                    "ticker_sentiment_score": "-0.130868",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "FDA Expands Lilly  ( LLY )  Jardiance Label in Chronic Kidney Disease",
            "url": "https://www.zacks.com/stock/news/2155039/fda-expands-lilly-lly-jardiance-label-in-chronic-kidney-disease",
            "time_published": "20230925T160400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Following the latest approval, Lilly's (LLY) Jardiance can access a target market that affects more than 35 million adults in the United States.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.96136"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.147868,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ANVS",
                    "relevance_score": "0.186738",
                    "ticker_sentiment_score": "0.043115",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.568953",
                    "ticker_sentiment_score": "0.173008",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.306198",
                    "ticker_sentiment_score": "0.071326",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know",
            "url": "https://www.zacks.com/stock/news/2154763/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know",
            "time_published": "20230925T130011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default343.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                }
            ],
            "overall_sentiment_score": 0.243948,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.520209",
                    "ticker_sentiment_score": "0.143271",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Invesco Pharmaceuticals ETF  ( PJP ) ?",
            "url": "https://www.zacks.com/stock/news/2154633/should-you-invest-in-the-invesco-pharmaceuticals-etf-pjp",
            "time_published": "20230925T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default85.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.164233,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.196877",
                    "ticker_sentiment_score": "0.100763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132004",
                    "ticker_sentiment_score": "0.063692",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Artificial Intelligence  ( AI )  Stocks That Could Soar More Than Nvidia, According to Wall Street",
            "url": "https://www.fool.com/investing/2023/09/25/artificial-intelligence-ai-stocks-soar-nvidia/",
            "time_published": "20230925T095000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "None of these stocks have outperformed Nvidia so far this year. But the next 12 months could be a different story.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.796627"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.650727"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.234495,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.230235",
                    "ticker_sentiment_score": "0.264104",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SOUN",
                    "relevance_score": "0.230235",
                    "ticker_sentiment_score": "0.239579",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "-0.031977",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SDGR",
                    "relevance_score": "0.391486",
                    "ticker_sentiment_score": "0.356966",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HMC",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.05833",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Magnificent Growth Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2023/09/24/3-magnificent-growth-stocks-to-buy-right-now/",
            "time_published": "20230924T105000",
            "authors": [
                "David Jagielski",
                "and Prosper Junior Bakiny",
                "Keith Speights"
            ],
            "summary": "If you're looking for growth, these stocks could be just the ticket.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.459462"
                }
            ],
            "overall_sentiment_score": 0.352979,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.166743",
                    "ticker_sentiment_score": "0.245837",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.12546",
                    "ticker_sentiment_score": "0.201716",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.287441",
                    "ticker_sentiment_score": "0.437472",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase - Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Meta Platforms  ( NASDAQ:META ) , NVIDIA  ( NASDAQ:NVDA ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/09/34825151/stocks-in-monopolistic-bull-market-wall-street-analyst-contemplates-a-bright-future",
            "time_published": "20230922T144619",
            "authors": [
                "Piero Cingari"
            ],
            "summary": "This year's bull market in stocks is a reflection of a bull market in monopolies and oligopolies, according to Bank of America's Chief Investment Strategist Michael Hartnett. While the S&P 500 boasts a commendable 14% year-to-date ( YTD ) increase, a closer look reveals the real action lies ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/Bull.Shutterstock.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.905476"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                }
            ],
            "overall_sentiment_score": 0.232814,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.103319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.103319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.103319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UAL",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.057826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.103319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.411679",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.103319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.070762",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.103319",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BX",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.070762",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "-0.057826",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.070762",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WMT",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.070762",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Are Wall Street Analysts Wrong About Eli Lilly Stock?",
            "url": "https://www.fool.com/investing/2023/09/22/are-wall-street-analysts-wrong-about-eli-lilly/",
            "time_published": "20230922T134500",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747921%2Fupside-for-eli-lillys-stock-based-on-most-recent-analyst-estimates.png&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99989"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                }
            ],
            "overall_sentiment_score": 0.21918,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.366061",
                    "ticker_sentiment_score": "0.23249",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "The Zacks Analyst Blog Highlights Eli Lilly, Toyota Motor, Accenture, The Walt Disney and CVS Health",
            "url": "https://www.zacks.com/stock/news/2154253/the-zacks-analyst-blog-highlights-eli-lilly-toyota-motor-accenture-the-walt-disney-and-cvs-health",
            "time_published": "20230922T130700",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly, Toyota Motor, Accenture, The Walt Disney and CVS Health are part of the Zacks top Analyst Blog.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/2922.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.199173,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CURN",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "-0.105437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVS",
                    "relevance_score": "0.136888",
                    "ticker_sentiment_score": "0.033574",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "G",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "-0.105437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.395012",
                    "ticker_sentiment_score": "0.148202",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TM",
                    "relevance_score": "0.269776",
                    "ticker_sentiment_score": "0.106414",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INFY",
                    "relevance_score": "0.068698",
                    "ticker_sentiment_score": "-0.105437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.395012",
                    "ticker_sentiment_score": "0.377147",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "DIS",
                    "relevance_score": "0.136888",
                    "ticker_sentiment_score": "0.033574",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "US FDA approves Jardiance for the treatment of adults with chronic kidney disease - PR Newswire",
            "url": "https://www.prnewswire.com/news-releases/us-fda-approves-jardiance-for-the-treatment-of-adults-with-chronic-kidney-disease-301936176.html",
            "time_published": "20230922T123300",
            "authors": [],
            "summary": "US FDA approves Jardiance for the treatment of adults with chronic kidney disease PR ...",
            "banner_image": null,
            "source": "PR Newswire",
            "category_within_source": "n/a",
            "source_domain": "www.prnewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.004877,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "HESG",
                    "relevance_score": "0.019602",
                    "ticker_sentiment_score": "0.014915",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.194086",
                    "ticker_sentiment_score": "0.094689",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.019602",
                    "ticker_sentiment_score": "0.154946",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "7 Stocks Soar More Than 90% Even As Fed Hikes Rates",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-stocks-jump-more-than-following-the-feds-rate-hikes/",
            "time_published": "20230922T120000",
            "authors": [
                "MATT KRANTZ",
                "Investor's Business Daily"
            ],
            "summary": "Who says higher interest rates are bad for S&P 500 stocks? A select group is thriving even as the Federal Reserve hikes rates.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/04/econ01-fed-040517-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.255107,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.172919",
                    "ticker_sentiment_score": "0.189242",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MPC",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.135146",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.115787",
                    "ticker_sentiment_score": "0.135146",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.058047",
                    "ticker_sentiment_score": "0.121986",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FSLR",
                    "relevance_score": "0.172919",
                    "ticker_sentiment_score": "0.180895",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CEG",
                    "relevance_score": "0.172919",
                    "ticker_sentiment_score": "0.261195",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's a rapid-fire update on all 35 stocks in the Club's portfolio, including a new buy",
            "url": "https://www.cnbc.com/2023/09/21/rapid-fire-update-on-all-35-stocks-in-jim-cramers-club-portfolio.html",
            "time_published": "20230921T192259",
            "authors": [
                "Kevin Stankiewicz"
            ],
            "summary": "Jim Cramer ran through all 35 Club stocks during our September Monthly Meeting on Thursday.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107200467-1677528554270-NUP_200782_00122.jpg?v=1695324179&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.142857"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.714479"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.142857"
                }
            ],
            "overall_sentiment_score": 0.209065,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "DD",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.099394",
                    "ticker_sentiment_score": "0.095909",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "F",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "FL",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WYNN",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NATI",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CLX",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DHR",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COST",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SBUX",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STZ",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PANW",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HUM",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TJX",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HON",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SWK",
                    "relevance_score": "0.019928",
                    "ticker_sentiment_score": "0.080807",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "EMR",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LIN",
                    "relevance_score": "0.059736",
                    "ticker_sentiment_score": "0.08825",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CAT",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PG",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PXD",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.07959",
                    "ticker_sentiment_score": "0.090866",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTRA",
                    "relevance_score": "0.039844",
                    "ticker_sentiment_score": "0.086994",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Research Reports for Eli Lilly, Toyota Motor, Accenture & Others",
            "url": "https://www.zacks.com/research-daily/2153717/top-research-reports-for-eli-lilly-toyota-motor-accenture-others",
            "time_published": "20230921T155700",
            "authors": [
                "Sheraz Mian"
            ],
            "summary": "Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Toyota Motor Corporation (TM) and Accenture plc (ACN).",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default76.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.158519"
                }
            ],
            "overall_sentiment_score": 0.245897,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.19661",
                    "ticker_sentiment_score": "0.187397",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CURN",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "-0.114813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TM",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "0.11763",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INFY",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "-0.114813",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.19661",
                    "ticker_sentiment_score": "0.449485",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "G",
                    "relevance_score": "0.099066",
                    "ticker_sentiment_score": "-0.114813",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medtech Makers Are Real Losers From Obesity Drugs",
            "url": "https://www.barrons.com/articles/weight-loss-drugs-obesity-eli-lilly-novo-nordisk-bcd3dd6e",
            "time_published": "20230921T050000",
            "authors": [
                "Bill Alpert"
            ],
            "summary": "Weight-Loss Drugs Are Bad News for Companies That Treat Obesity ... ...",
            "banner_image": "https://images.barrons.com/im-06751388?width=700&height=466",
            "source": "Barrons",
            "category_within_source": "n/a",
            "source_domain": "www.barrons.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.119443,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "INSP",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.161174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TNDM",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.161174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.428457",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.428457",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MDGL",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.161174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "RMD",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.161174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "PODD",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.161174",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.586747",
                    "ticker_sentiment_score": "0.049711",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Peering Into Eli Lilly's Recent Short Interest - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/short-sellers/23/09/34772303/peering-into-eli-lillys-recent-short-interest",
            "time_published": "20230920T194536",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly's LLY short percent of float has risen 9.23% since its last report. The company recently reported that it has 5.62 million shares sold short, which is 0.71% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.55 days to cover their ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.265104,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.15378",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Drug Giant Hits Profit Zone Amid Enthusiasm For Weight Loss Drug",
            "url": "https://www.investors.com/stock-lists/stock-spotlight/eli-lilly-stock-hits-profit-zone-amid-enthusiasm-for-weight-loss-drug/",
            "time_published": "20230920T185300",
            "authors": [
                "SCOTT LEHTONEN",
                "Investor's Business Daily"
            ],
            "summary": "Drugmaker Eli Lilly ( LLY ) hit a profit zone amid a string of torrid gains, as Wall Street remains enthusiastic over the prospects for weight-loss drugs. Eli Lilly stock is a member of IBD's Stock Spotlight list. Eli Lilly is set to rival Novo Nordisk ( NVO ) , the current leader in obesity ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2018/12/stock-Eli-Lilly-02-Shutter.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999998"
                }
            ],
            "overall_sentiment_score": 0.321887,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "GLDAF",
                    "relevance_score": "0.08687",
                    "ticker_sentiment_score": "0.025076",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.673811",
                    "ticker_sentiment_score": "0.5238",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.172713",
                    "ticker_sentiment_score": "-0.034237",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Top Stories Wednesday, Sep 20: Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge - Apple  ( NASDAQ:AAPL ) , Amazon.com  ( NASDAQ:AMZN ) ",
            "url": "https://www.benzinga.com/news/23/09/34763015/elon-musk-backed-neuralink-starts-participant-enrollment-for-paralysis-eli-lilly-cracks-down-on-coun",
            "time_published": "20230920T135614",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Elon Musk's brain-computer interface company, Neuralink, has initiated recruiting its first test subjects for human trials aimed at assisting individuals with paralysis in controlling devices.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/20/neuralink_elon_musk_jr_morty_and_jlstock_on_shutterstock.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                }
            ],
            "overall_sentiment_score": 0.062611,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.008111",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.137278",
                    "ticker_sentiment_score": "-0.091478",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.17112",
                    "ticker_sentiment_score": "-0.066313",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPRY",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "-0.149649",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "F",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "-0.318343",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.100352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "QUBSF",
                    "relevance_score": "0.03448",
                    "ticker_sentiment_score": "0.15318",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "COTY",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.260647",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GIS",
                    "relevance_score": "0.103183",
                    "ticker_sentiment_score": "0.050609",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INTC",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.246494",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.103183",
                    "ticker_sentiment_score": "-0.029223",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PINS",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.094322",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOOD",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.057162",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PM",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BA",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.068896",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Cracks Down on Counterfeit Mounjaro Weight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34757757/eli-lilly-cracks-down-on-counterfeit-mounjaro-weight-loss-and-diabetes-drugs-sues-lawsuit-against",
            "time_published": "20230920T131854",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY has taken legal action against ten entities in the U.S., including medical spas, wellness centers, and compounding pharmacies, alleging that they have been selling unauthorized, less expensive versions of its diabetes drug, Mounjaro ( tirzepatide ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/20/mounjaro-medication-for-weight-loss.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.036823,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.60326",
                    "ticker_sentiment_score": "0.104015",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.265378",
                    "ticker_sentiment_score": "-0.150153",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34757757/eli-lilly-cracks-down-on-counterfeit-mounjaro-wight-loss-and-diabetes-drugs-sues-lawsuit-against-",
            "time_published": "20230920T131854",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Eli Lilly And Co LLY has taken legal action against ten entities in the U.S., including medical spas, wellness centers, and compounding pharmacies, alleging that they have been selling unauthorized, less expensive versions of its diabetes drug, Mounjaro ( tirzepatide ) .",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/20/mounjaro-medication-for-weight-loss.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": -0.036823,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.60326",
                    "ticker_sentiment_score": "0.104015",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.265378",
                    "ticker_sentiment_score": "-0.150153",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Should You Invest in the iShares U.S. Healthcare ETF  ( IYH ) ?",
            "url": "https://www.zacks.com/stock/news/2152866/should-you-invest-in-the-ishares-us-healthcare-etf-iyh",
            "time_published": "20230920T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default67.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.228879,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "BLK",
                    "relevance_score": "0.066414",
                    "ticker_sentiment_score": "0.088153",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.132368",
                    "ticker_sentiment_score": "0.069712",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.132368",
                    "ticker_sentiment_score": "0.069712",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.132368",
                    "ticker_sentiment_score": "0.069712",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years",
            "url": "https://www.fool.com/investing/2023/09/20/3-healthcare-stocks-that-turned-100000-into-1-mill/",
            "time_published": "20230920T093900",
            "authors": [
                "David Jagielski"
            ],
            "summary": "Are these highly successful stocks still good buys today?",
            "banner_image": "https://media.ycharts.com/charts/baf7a2c02e6b9383f1853d6d4357574c.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.658903"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.995973"
                }
            ],
            "overall_sentiment_score": 0.327785,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.280294",
                    "ticker_sentiment_score": "0.164338",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WST",
                    "relevance_score": "0.22595",
                    "ticker_sentiment_score": "0.23179",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.22595",
                    "ticker_sentiment_score": "0.206779",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "6 Healthcare Stocks Analysts Still Like",
            "url": "https://www.barrons.com/articles/healthcare-stocks-analysts-like-8b0f4dd2",
            "time_published": "20230920T070000",
            "authors": [
                "Josh Nathan-Kazis"
            ],
            "summary": "This has been an epically bad year for the healthcare sector, but there are still a few stocks out there that Wall Street analysts like. Some of them are even more beaten down than the rest of the industry. The S&P 500 Health Care sector index is down 3% this year, vastly behind the S&P 500, ...",
            "banner_image": "https://images.barrons.com/im-81046107?width=639&height=426",
            "source": "Barrons",
            "category_within_source": "n/a",
            "source_domain": "www.barrons.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.918141"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.495866"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.054264,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "TECH",
                    "relevance_score": "0.240489",
                    "ticker_sentiment_score": "0.079998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BSX",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.059347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.059347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.059347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.459624",
                    "ticker_sentiment_score": "0.130657",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIO",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.059347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DXCM",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.059347",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.16171",
                    "ticker_sentiment_score": "0.059347",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Gains As Market Dips: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2152758/eli-lilly-lly-gains-as-market-dips-what-you-should-know",
            "time_published": "20230919T214518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "In the latest trading session, Eli Lilly (LLY) closed at $574.96, marking a +0.64% move from the previous day.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default122.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.961735"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                }
            ],
            "overall_sentiment_score": 0.124548,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.5633",
                    "ticker_sentiment_score": "0.108351",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34734299/eli-lilly-unusual-options-activity",
            "time_published": "20230919T151547",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://www.benzinga.com/files/images/story/2023/1695136544_0.png",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.118395,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.753462",
                    "ticker_sentiment_score": "0.070095",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.102449",
                    "ticker_sentiment_score": "-0.124255",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Health Care Select Sector SPDR ETF  ( XLV ) ?",
            "url": "https://www.zacks.com/stock/news/2151652/should-you-invest-in-the-health-care-select-sector-spdr-etf-xlv",
            "time_published": "20230918T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default109.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.258161,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "0.063548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.063425",
                    "ticker_sentiment_score": "0.127352",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.063425",
                    "ticker_sentiment_score": "0.089045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "0.063548",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.12645",
                    "ticker_sentiment_score": "0.063548",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Invesco Large Cap Growth ETF  ( PWB )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2151646/should-invesco-large-cap-growth-etf-pwb-be-on-your-investing-radar",
            "time_published": "20230918T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default224.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.302328,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.0608",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.0608",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.119235",
                    "ticker_sentiment_score": "0.0608",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.29234",
                    "ticker_sentiment_score": "0.265446",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is SPDR S&P Pharmaceuticals ETF  ( XPH )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2151658/is-spdr-sp-pharmaceuticals-etf-xph-a-strong-etf-right-now",
            "time_published": "20230918T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default285.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999953"
                }
            ],
            "overall_sentiment_score": 0.197567,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.11123",
                    "ticker_sentiment_score": "0.056993",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "STT",
                    "relevance_score": "0.055751",
                    "ticker_sentiment_score": "0.065881",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELAN",
                    "relevance_score": "0.11123",
                    "ticker_sentiment_score": "0.056993",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "RETA",
                    "relevance_score": "0.11123",
                    "ticker_sentiment_score": "0.056993",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030",
            "url": "https://www.fool.com/investing/2023/09/16/1-growth-stock-that-could-turn-1000-into-2500-by-2/",
            "time_published": "20230916T111500",
            "authors": [
                "Prosper Junior Bakiny"
            ],
            "summary": "The stock has delivered market-beating returns in the past. It can do it again.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.684621"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.224724,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.230381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.108466",
                    "ticker_sentiment_score": "0.068966",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "My Top Small-Cap Pick for a Strong Year-End Run",
            "url": "https://realmoney.thestreet.com/investing/stocks/my-top-small-cap-pick-for-a-strong-year-end-run-16133297",
            "time_published": "20230915T153000",
            "authors": [
                "James \"Rev Shark\" DePorre"
            ],
            "summary": "On Tuesday, I discussed Uber ( UBER ) , which is my top large-cap pick for a strong year-end run. Today, I want to discuss my top small-cap pick for a strong year-end run. My pick is LifeMD ( LFMD ) . LifeMD has a market cap of around $168 million with about 36 million shares outstanding.",
            "banner_image": "https://s.thestreet.com/files/tsc/v2008/photos/contrib/uploads/a49b1bcd-5333-11ee-92a9-11685bebb03f.jpg",
            "source": "The Street",
            "category_within_source": "GoogleRSS",
            "source_domain": "realmoney.thestreet.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.239314,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.163769",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LFMD",
                    "relevance_score": "0.417995",
                    "ticker_sentiment_score": "0.002841",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MED",
                    "relevance_score": "0.109455",
                    "ticker_sentiment_score": "-0.024638",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UBER",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.496199",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.21686",
                    "ticker_sentiment_score": "0.163769",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Is Invesco Large Cap Growth ETF  ( PWB )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2149297/is-invesco-large-cap-growth-etf-pwb-a-strong-etf-right-now",
            "time_published": "20230915T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default93.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999759"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.305094,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.055265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.055265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.11983",
                    "ticker_sentiment_score": "0.055265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.293741",
                    "ticker_sentiment_score": "0.389101",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Novo Nordisk  ( NVO )  Announces Stock Split to Enhance Liquidity",
            "url": "https://www.zacks.com/stock/news/2149069/novo-nordisk-nvo-announces-stock-split-to-enhance-liquidity",
            "time_published": "20230914T152800",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Novo Nordisk (NVO) conducts a two-for-one stock split. While this is already in effect at the stock exchange in Denmark, the ADRs listed on the NYSE will be split in the same ratio by next week.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                }
            ],
            "overall_sentiment_score": 0.081997,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.314017",
                    "ticker_sentiment_score": "0.131476",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.482304",
                    "ticker_sentiment_score": "0.063392",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.314017",
                    "ticker_sentiment_score": "0.041002",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Nektar  ( NKTR )  Up on Positive New Data From Eczema Study",
            "url": "https://www.zacks.com/stock/news/2148794/nektar-nktr-up-on-positive-new-data-from-eczema-study",
            "time_published": "20230914T115400",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Nektar (NKTR) gains on positive new data for its pipeline candidate, rezpegaldesleukin, evaluated from an early-stage study for treating atopic dermatitis.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.004815,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.383905",
                    "ticker_sentiment_score": "-0.057357",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANIK",
                    "relevance_score": "0.132733",
                    "ticker_sentiment_score": "0.067432",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANVS",
                    "relevance_score": "0.261818",
                    "ticker_sentiment_score": "-0.057928",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NKTR",
                    "relevance_score": "0.261818",
                    "ticker_sentiment_score": "0.02199",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Franklin U.S. Large Cap Multifactor Index ETF  ( FLQL )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2148717/is-franklin-us-large-cap-multifactor-index-etf-flql-a-strong-etf-right-now",
            "time_published": "20230914T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default276.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.186333,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.054931",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.054931",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.112008",
                    "ticker_sentiment_score": "0.054931",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "2 Stocks That Moved the Market in August",
            "url": "https://www.fool.com/investing/2023/09/14/2-stocks-that-moved-the-market-in-august/",
            "time_published": "20230914T095500",
            "authors": [
                "Ryan Downie"
            ],
            "summary": "These two stocks illustrate the most important trends in the market right now.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747424%2Fgettyimages-1346195016.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.955357"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Blockchain",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.03242,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.128822",
                    "ticker_sentiment_score": "0.199274",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SQ",
                    "relevance_score": "0.213048",
                    "ticker_sentiment_score": "0.083228",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CRYPTO:BTC",
                    "relevance_score": "0.08609",
                    "ticker_sentiment_score": "0.043966",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Zacks Investment Ideas feature highlights: Novo Nordisk, Eli Lilly and AbbVie",
            "url": "https://www.zacks.com/stock/news/2148692/zacks-investment-ideas-feature-highlights-novo-nordisk-eli-lilly-and-abbvie",
            "time_published": "20230914T090000",
            "authors": [
                "Zacks Investment Research"
            ],
            "summary": "Novo Nordisk, Eli Lilly and AbbVie have been highlighted in this Investment Ideas article.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.495866"
                }
            ],
            "overall_sentiment_score": 0.14237,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.337427",
                    "ticker_sentiment_score": "0.312738",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.337427",
                    "ticker_sentiment_score": "0.312738",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.414559",
                    "ticker_sentiment_score": "0.393752",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly  ( LLY )  Stock Sinks As Market Gains: What You Should Know",
            "url": "https://www.zacks.com/stock/news/2148585/eli-lilly-lly-stock-sinks-as-market-gains-what-you-should-know",
            "time_published": "20230913T214518",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Eli Lilly (LLY) closed the most recent trading day at $598.88, moving -0.07% from the previous trading session.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default309.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976913"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                }
            ],
            "overall_sentiment_score": 0.176825,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.6809",
                    "ticker_sentiment_score": "0.259595",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results",
            "url": "https://www.globenewswire.com/news-release/2023/09/13/2742872/0/en/Scinai-Immunotherapeutics-Innovative-Plaque-Psoriasis-Treatment-Shows-Encouraging-Preclinical-Results.html",
            "time_published": "20230913T201300",
            "authors": [
                "Scinai Immunotherapeutics Ltd."
            ],
            "summary": "Scinai's NanoAbs downregulated key molecular markers overexpressed in plaque psoriasis ...",
            "banner_image": "https://ml.globenewswire.com/Resource/Download/f1d5f17b-bd34-4faf-8359-6f195754edd9",
            "source": "GlobeNewswire",
            "category_within_source": "n/a",
            "source_domain": "www.globenewswire.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.360215"
                }
            ],
            "overall_sentiment_score": 0.002409,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.0686",
                    "ticker_sentiment_score": "-0.024257",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MLTX",
                    "relevance_score": "0.0686",
                    "ticker_sentiment_score": "-0.024257",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "\"Blockbuster Status\": 3 Bios to Buy and Hold",
            "url": "https://www.zacks.com/commentary/2148551/blockbuster-status-3-bios-to-buy-and-hold",
            "time_published": "20230913T183400",
            "authors": [
                "Andrew Rocco"
            ],
            "summary": "The biotech sector is notorious for its sky-high R&D costs, regulatory hurdles, and lengthy timelines to bring a drug to market. Stock Strategist Andrew Rocco unveils 3 biotech stocks that have broken through and are set up for long term growth.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/51032.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.16147,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.255641",
                    "ticker_sentiment_score": "0.326909",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.33628",
                    "ticker_sentiment_score": "0.487247",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "This Stock Once Jumped 268% On FDA Action; Can It Do That Again?",
            "url": "https://www.investors.com/news/technology/mdgl-stock-jumps-as-its-nash-treatment-toes-the-long-awaited-finish-line/",
            "time_published": "20230913T160900",
            "authors": [
                "ALLISON GATLIN",
                "Investor's Business Daily"
            ],
            "summary": "MDGL Stock Jumps As Its NASH Treatment Toes The Long-Awaiting ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2017/11/stock-biotech-05-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.262821,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "SLRN",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.11589",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DSSMY",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.231953",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.159342",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.159342",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MDGL",
                    "relevance_score": "0.393977",
                    "ticker_sentiment_score": "0.491279",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "MRNA",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "-0.191908",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "-0.191908",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                }
            ]
        },
        {
            "title": "Altimmune  ( ALT )  Rises 7% on Completing Dosing in Obesity Study",
            "url": "https://www.zacks.com/stock/news/2148179/altimmune-alt-rises-7-on-completing-dosing-in-obesity-study",
            "time_published": "20230913T113000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Altimmune (ALT) completes the dosing of all patients in the mid-stage obesity study of pemvidutide. The company remains on track to announce top-line results in fourth-quarter 2023. The stock rises 7%.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/82/41137.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.155306,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.188193",
                    "ticker_sentiment_score": "0.180637",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALT",
                    "relevance_score": "0.407844",
                    "ticker_sentiment_score": "0.239752",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.141726",
                    "ticker_sentiment_score": "0.088988",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.234006",
                    "ticker_sentiment_score": "0.129318",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is First Trust Capital Strength ETF  ( FTCS )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2148129/is-first-trust-capital-strength-etf-ftcs-a-strong-etf-right-now",
            "time_published": "20230913T102005",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default275.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999965"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.313262,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "CPRT",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.055415",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.055415",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NTAP",
                    "relevance_score": "0.114682",
                    "ticker_sentiment_score": "0.055415",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Check Out What Whales Are Doing With LLY - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34496053/check-out-what-whales-are-doing-with-lly",
            "time_published": "20230912T154653",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bullish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.143764,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.75957",
                    "ticker_sentiment_score": "0.218609",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.103778",
                    "ticker_sentiment_score": "-0.124737",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "NVS vs. LLY: Which Stock Is the Better Value Option?",
            "url": "https://www.zacks.com/stock/news/2147891/nvs-vs-lly-which-stock-is-the-better-value-option",
            "time_published": "20230912T154007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Investors interested in Large Cap Pharmaceuticals stocks are likely familiar with Novartis ( NVS Quick QuoteNVS - ) and Eli Lilly ( LLY Quick QuoteLLY - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default45.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.511391,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.757528",
                    "ticker_sentiment_score": "0.612371",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Jim Cramer says this software stock is a buy here after earnings-driven decline",
            "url": "https://www.cnbc.com/2023/09/12/jim-cramer-says-this-software-stock-is-a-buy-here-.html",
            "time_published": "20230912T151429",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107299151-16945293921694529386-31166084386-1080pnbcnews.jpg?v=1694530658&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.166134,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.433523",
                    "ticker_sentiment_score": "0.201767",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ORCL",
                    "relevance_score": "0.49637",
                    "ticker_sentiment_score": "0.219566",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.297661",
                    "ticker_sentiment_score": "0.153721",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "We're selling shares in this outperforming drugmaker and locking in a huge gain",
            "url": "https://www.cnbc.com/2023/09/12/were-selling-shares-in-this-healthcare-stock-and-locking-in-some-major-gains.html",
            "time_published": "20230912T130403",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "This trim today is about discipline after an incredible run in a stock.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107261717-1687534870894-gettyimages-492437674-Par8299504.jpeg?v=1694523843&w=1920&h=1080",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.986714"
                }
            ],
            "overall_sentiment_score": 0.329256,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.7887",
                    "ticker_sentiment_score": "0.518668",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( LLY )  is Attracting Investor Attention: Here is What You Should Know",
            "url": "https://www.zacks.com/stock/news/2147650/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know",
            "time_published": "20230912T130011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default214.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                }
            ],
            "overall_sentiment_score": 0.230595,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.525907",
                    "ticker_sentiment_score": "0.17223",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "LLY: Prescribe to Profits With These 3 Pharma Stocks",
            "url": "https://stocknews.com/news/lly-mrk-teva-prescribe-to-profits-with-these-3-pharma-stocks/",
            "time_published": "20230912T125425",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The pharmaceutical industry is a robust and continually evolving sector, poised for sustained growth in the coming years, driven by several factors, including an aging global population, the rising incidence of chronic illnesses, and technological advancements.",
            "banner_image": "https://stocknews.com/wp-content/uploads/2021/01/cvs-rad-wba-scaled.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.998356"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.99999"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.258224,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.199977",
                    "ticker_sentiment_score": "0.224082",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALVO",
                    "relevance_score": "0.057698",
                    "ticker_sentiment_score": "0.085962",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TEVA",
                    "relevance_score": "0.171892",
                    "ticker_sentiment_score": "0.153254",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SGTX",
                    "relevance_score": "0.028868",
                    "ticker_sentiment_score": "0.258329",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Should You Still Buy the S&P 500's Best-Performing August Stocks?",
            "url": "https://www.fool.com/investing/2023/09/12/should-you-still-buy-the-sp-500s-best-performing-a/",
            "time_published": "20230912T095000",
            "authors": [
                "Keith Speights"
            ],
            "summary": "These high-flying S&P 500 stocks could have more room to run.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.5855"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999999"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.278345,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "JNPR",
                    "relevance_score": "0.062271",
                    "ticker_sentiment_score": "0.140499",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.415535",
                    "ticker_sentiment_score": "0.445579",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.185306",
                    "ticker_sentiment_score": "0.282323",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.",
            "url": "https://www.fool.com/investing/2023/09/12/wall-street-has-next-high-flying-stock-split-stock/",
            "time_published": "20230912T090600",
            "authors": [
                "Sean Williams"
            ],
            "summary": "Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive club.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F747197%2Fstock-certificate-investment-retire-heirloom-donate-capital-gains-tax-getty.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999976"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.147951,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.032164",
                    "ticker_sentiment_score": "0.147186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.032164",
                    "ticker_sentiment_score": "0.147186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.032164",
                    "ticker_sentiment_score": "0.147186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MNST",
                    "relevance_score": "0.032164",
                    "ticker_sentiment_score": "0.270996",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.399856",
                    "ticker_sentiment_score": "0.150249",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.142446",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.032164",
                    "ticker_sentiment_score": "0.147186",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.064276",
                    "ticker_sentiment_score": "0.142446",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Is Invesco S&P 500 Equal Weight Health Care ETF  ( RSPH )  a Strong ETF Right Now?",
            "url": "https://www.zacks.com/stock/news/2147014/is-invesco-sp-500-equal-weight-health-care-etf-rsph-a-strong-etf-right-now",
            "time_published": "20230911T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Smart Beta ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default28.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999759"
                }
            ],
            "overall_sentiment_score": 0.326498,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.12013",
                    "ticker_sentiment_score": "0.056456",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ALGN",
                    "relevance_score": "0.12013",
                    "ticker_sentiment_score": "0.056456",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.179343",
                    "ticker_sentiment_score": "0.326194",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VTRS",
                    "relevance_score": "0.12013",
                    "ticker_sentiment_score": "0.056456",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should You Invest in the Vanguard Health Care ETF  ( VHT ) ?",
            "url": "https://www.zacks.com/stock/news/2147010/should-you-invest-in-the-vanguard-health-care-etf-vht",
            "time_published": "20230911T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Sector ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default221.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.2532,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.064794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.068502",
                    "ticker_sentiment_score": "0.125901",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.064794",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JNJ",
                    "relevance_score": "0.136499",
                    "ticker_sentiment_score": "0.064794",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.",
            "url": "https://www.fool.com/investing/2023/09/10/investors-may-not-have-seen-the-best-from-eli-lill/",
            "time_published": "20230910T101200",
            "authors": [
                "Adam Spatacco"
            ],
            "summary": "Mounjaro has been on the market for roughly one year and is already generating billions in sales for Eli Lilly. But with that said, its best days could be ahead.",
            "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F745741%2Fgettyimages-1315185865.jpg&op=resize&w=700",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.839681"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.15603,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.609866",
                    "ticker_sentiment_score": "0.228644",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.303926",
                    "ticker_sentiment_score": "0.023955",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "3 Unstoppable Growth Stocks to Buy Right Now",
            "url": "https://www.fool.com/investing/2023/09/09/3-unstoppable-growth-stocks-to-buy-right-now/",
            "time_published": "20230909T105500",
            "authors": [
                "and Prosper Junior Bakiny",
                "David Jagielski",
                "Keith Speights"
            ],
            "summary": "These healthcare stocks show no signs of slowing down.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                }
            ],
            "overall_sentiment_score": 0.247559,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.285526",
                    "ticker_sentiment_score": "0.177763",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "VRTX",
                    "relevance_score": "0.165598",
                    "ticker_sentiment_score": "0.085992",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "REGN",
                    "relevance_score": "0.165598",
                    "ticker_sentiment_score": "0.085386",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SNY",
                    "relevance_score": "0.041682",
                    "ticker_sentiment_score": "0.244904",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Only 2 Mega-Cap Monster Stocks Have Risen in Each of the Last 5 Years: Are They Buys Now?",
            "url": "https://www.fool.com/investing/2023/09/09/here-are-the-only-2-mega-cap-monster-stocks-that-h/",
            "time_published": "20230909T095200",
            "authors": [
                "Keith Speights"
            ],
            "summary": "There's no guarantee their winning streaks will continue. But don't be surprised if they do.",
            "banner_image": "https://media.ycharts.com/charts/6c63e09bdd88a1417b73b666ca53fea7.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.451494"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.234418,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.429541",
                    "ticker_sentiment_score": "0.24195",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.05654",
                    "ticker_sentiment_score": "0.115259",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.05654",
                    "ticker_sentiment_score": "0.115259",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.277118",
                    "ticker_sentiment_score": "0.275632",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Drug And Tech Services Stocks Surge To New Highs, Buy Zones With Strong Technical Ratings",
            "url": "https://www.investors.com/stock-lists/new-highs/drug-and-tech-services-stocks-surge-to-new-highs-with-strong-technical-ratings/",
            "time_published": "20230908T162700",
            "authors": [
                "VIDYA RAMAKRISHNAN",
                "Investor's Business Daily"
            ],
            "summary": "Drug And Tech Services Stocks Surge To New Highs, Buy Zones ... Investor's Business Daily ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2020/10/Stock-EliLilly-03-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.744043"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                }
            ],
            "overall_sentiment_score": 0.362345,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "ACN",
                    "relevance_score": "0.303175",
                    "ticker_sentiment_score": "0.366788",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.303175",
                    "ticker_sentiment_score": "0.436939",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Alector  ( ALEC )  Up 7% on Finishing Enrolment in Alzheimer Study",
            "url": "https://www.zacks.com/stock/news/2146781/alector-alec-up-7-on-finishing-enrolment-in-alzheimer-study",
            "time_published": "20230908T161000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Alector (ALEC) completes enrolment in a mid-stage study evaluating its investigational monoclonal antibody in patients with early Alzheimer's disease. Data from the study is expected before year-end.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.181653,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.295155",
                    "ticker_sentiment_score": "0.138053",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ABBV",
                    "relevance_score": "0.350564",
                    "ticker_sentiment_score": "0.321404",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ALEC",
                    "relevance_score": "0.675301",
                    "ticker_sentiment_score": "0.329413",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.179788",
                    "ticker_sentiment_score": "0.168865",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Top Stories Friday, Sep 8: Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects - Apple  ( NASDAQ:AAPL ) , Albertsons Companies  ( NYSE:ACI ) ",
            "url": "https://www.benzinga.com/news/23/09/34363050/did-elon-musk-admit-90-decline-in-twitters-value-since-acquisition-apples-zero-click-vulnerabilities",
            "time_published": "20230908T143216",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "Elon Musk's $44 billion acquisition of Twitter ( now X ) has been mired in controversies, but his latest admission could be a sign of just how bad it has turned out for him so far.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/08/elon_musk_should_run_from_the_twitter_deal_ljupco_smokovski_by_shutterstock_and_wikimedia_commons.jpg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.316726"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.166667"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.02421,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GOOG",
                    "relevance_score": "0.139064",
                    "ticker_sentiment_score": "-0.231492",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "-0.008128",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CVX",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.035368",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPOT",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.113506",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ILMN",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.090027",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACI",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.126595",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "KR",
                    "relevance_score": "0.207275",
                    "ticker_sentiment_score": "0.07092",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "-0.102437",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.024304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZM",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.024304",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HOFT",
                    "relevance_score": "0.104531",
                    "ticker_sentiment_score": "-0.033671",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SFBQF",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.307496",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "SFTBF",
                    "relevance_score": "0.034933",
                    "ticker_sentiment_score": "0.298086",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.069798",
                    "ticker_sentiment_score": "0.19613",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "UK Authority Recommends Eli Lilly's Famed Diabetes Drug Mounjaro As New Treatment Option For Type 2 Diabetes - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/general/biotech/23/09/34358238/uk-authority-recommends-eli-lillys-famed-diabetes-drug-mounjaro-as-new-treatment-option-for-type-",
            "time_published": "20230908T133815",
            "authors": [
                "Vandana Singh"
            ],
            "summary": "UK's National Institute for Health and Care Excellence ( NICE ) has endorsed Eli Lilly And Co's LLY diabetes medication, Mounjaro ( tirzepatide ) , indicating it as a viable option for patients grappling with poorly controlled type 2 diabetes.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/08/lly.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.402868,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.470894",
                    "ticker_sentiment_score": "0.513297",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.325208",
                    "ticker_sentiment_score": "0.079727",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Zacks Investment Ideas feature highlights: IonQ, E.L.F Beauty, Amazon, Meta Platforms and Eli Lilly",
            "url": "https://www.zacks.com/stock/news/2146531/zacks-investment-ideas-feature-highlights-ionq-elf-beauty-amazon-meta-platforms-and-eli-lilly",
            "time_published": "20230908T123300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "IonQ, E.L.F Beauty, Amazon, Meta Platforms and Eli Lilly are part of the Zacks Investment Ideas article.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/53/49.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.980922"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.080073,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.181591",
                    "ticker_sentiment_score": "0.130966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.181591",
                    "ticker_sentiment_score": "0.130966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IONQ",
                    "relevance_score": "0.181591",
                    "ticker_sentiment_score": "0.089312",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.181591",
                    "ticker_sentiment_score": "0.130966",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HNST",
                    "relevance_score": "0.061003",
                    "ticker_sentiment_score": "-0.094346",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here's How Much You'd Have If You Invested $1000 in Eli Lilly a Decade Ago",
            "url": "https://www.zacks.com/stock/news/2146456/heres-how-much-youd-have-if-you-invested-1000-in-eli-lilly-a-decade-ago",
            "time_published": "20230908T123003",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Holding on to popular or trending stocks for the long-term can make your portfolio a winner.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default107.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.990999"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.614606"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.160458,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.618121",
                    "ticker_sentiment_score": "0.260381",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.024871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ELAN",
                    "relevance_score": "0.212115",
                    "ticker_sentiment_score": "0.040331",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AKUS",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.046012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DICE",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.046012",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVBXF",
                    "relevance_score": "0.053629",
                    "ticker_sentiment_score": "0.024871",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "'Smart Money' Investors Pour $2 Billion Into Just 5 Stocks",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-smart-money-investors-pour-billions-into-just-stocks/",
            "time_published": "20230908T120000",
            "authors": [
                "Investor's Business Daily",
                "MATT KRANTZ"
            ],
            "summary": "If you're wondering which S&P 500 stocks the best mutual funds are buying - you might be surprised by how selective the list is.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/04/Stock-moneyoncalendar-01-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.999998"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.389708,
            "overall_sentiment_label": "Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "META",
                    "relevance_score": "0.165031",
                    "ticker_sentiment_score": "0.067127",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.165031",
                    "ticker_sentiment_score": "0.331673",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "AVGO",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "0.169375",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "CSCO",
                    "relevance_score": "0.165031",
                    "ticker_sentiment_score": "0.28802",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.165031",
                    "ticker_sentiment_score": "0.153286",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "ADBE",
                    "relevance_score": "0.110462",
                    "ticker_sentiment_score": "0.169375",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.271576",
                    "ticker_sentiment_score": "0.323372",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BLD",
                    "relevance_score": "0.165031",
                    "ticker_sentiment_score": "0.253387",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Stocks Could Revive In September - But Don't Count On It",
            "url": "https://www.investors.com/etfs-and-funds/personal-finance/best-funds-stocks-could-revive-september/",
            "time_published": "20230908T110000",
            "authors": [
                "ADAM SHELL",
                "Investor's Business Daily"
            ],
            "summary": "Despite a late-month rally, both the S&P 500 and Nasdaq saw their five-month winning streaks snapped in August. The market suffered a broad but mild pullback, hurting even the best funds. The only stock fund sector to post a gain was natural resources, while the previously white-hot science and ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2021/04/Stock-marketBoard-29-adobe.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Energy & Transportation",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.838487"
                },
                {
                    "topic": "IPO",
                    "relevance_score": "0.310843"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.102673,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "-0.221314",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.086348",
                    "ticker_sentiment_score": "-0.231339",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.199741",
                    "ticker_sentiment_score": "0.067152",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "-0.221314",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "-0.221314",
                    "ticker_sentiment_label": "Somewhat-Bearish"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.0871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AEP",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.0861",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.028833",
                    "ticker_sentiment_score": "0.035485",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.0871",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NEE",
                    "relevance_score": "0.057628",
                    "ticker_sentiment_score": "0.0861",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "How Stocks Pass Quality Test Of This Best Mutual Fund",
            "url": "https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-fund-pass-the-quality-test-administered-by-quality-gmo-fund/",
            "time_published": "20230908T110000",
            "authors": [
                "Investor's Business Daily",
                "ADAM SHELL"
            ],
            "summary": "It doesn't take a Ph.D. in finance to figure out what the investing game plan is for GMO Quality IV Fund ( GQEFX ) , a best mutual fund. In a nutshell? Buy quality stocks. When administering the quality test, Tom Hancock, 60, portfolio manager of GMO Quality, looks for companies that can pretty ...",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/09/MFprof091123-959x1024.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.977154"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.891286"
                },
                {
                    "topic": "Economy - Macro",
                    "relevance_score": "0.310843"
                }
            ],
            "overall_sentiment_score": 0.290466,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "KLAC",
                    "relevance_score": "0.059562",
                    "ticker_sentiment_score": "0.070045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.059562",
                    "ticker_sentiment_score": "0.082998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.08924",
                    "ticker_sentiment_score": "0.085824",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.029802",
                    "ticker_sentiment_score": "0.066133",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.059562",
                    "ticker_sentiment_score": "0.082998",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.118793",
                    "ticker_sentiment_score": "0.290329",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "LRCX",
                    "relevance_score": "0.059562",
                    "ticker_sentiment_score": "0.070045",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.029802",
                    "ticker_sentiment_score": "-0.044174",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ACN",
                    "relevance_score": "0.08924",
                    "ticker_sentiment_score": "-0.003161",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.206308",
                    "ticker_sentiment_score": "0.095155",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "UNH",
                    "relevance_score": "0.08924",
                    "ticker_sentiment_score": "0.112787",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "4 Expert Tips for Navigating a Gap Down Market",
            "url": "https://www.zacks.com/commentary/2146200/4-expert-tips-for-navigating-a-gap-down-market",
            "time_published": "20230907T165300",
            "authors": [
                "Andrew Rocco"
            ],
            "summary": "Investors must learn to thrive in turbulent times. Stock Strategist Andrew Rocco provides 4 ways to hadle \"tape bombs\" ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/3f/49151.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Retail & Wholesale",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.962106"
                },
                {
                    "topic": "Real Estate & Construction",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.2"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.2"
                }
            ],
            "overall_sentiment_score": 0.060764,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.069768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.069768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IONQ",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.001191",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMZN",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.069768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "COIN",
                    "relevance_score": "0.123526",
                    "ticker_sentiment_score": "0.069768",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "HNST",
                    "relevance_score": "0.061949",
                    "ticker_sentiment_score": "0.001005",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Prothena  ( PRTA )  Skyrockets 88.7% in 12 Months: Here's Why",
            "url": "https://www.zacks.com/stock/news/2146171/prothena-prta-skyrockets-887-in-12-months-heres-why",
            "time_published": "20230907T160000",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Prothena (PRTA) gains a massive 88.7% in 12 months on pipeline progress with its AD candidates.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/88/898.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.221506,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.102231",
                    "ticker_sentiment_score": "-0.044978",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "PRTA",
                    "relevance_score": "0.347058",
                    "ticker_sentiment_score": "0.370312",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "ESALF",
                    "relevance_score": "0.051221",
                    "ticker_sentiment_score": "0.33079",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.102231",
                    "ticker_sentiment_score": "0.289694",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BMY",
                    "relevance_score": "0.152821",
                    "ticker_sentiment_score": "0.10643",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Is Lilly  ( LLY )  Up 6.4% Since Last Earnings Report?",
            "url": "https://www.zacks.com/stock/news/2146118/why-is-lilly-lly-up-64-since-last-earnings-report",
            "time_published": "20230907T153055",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default86.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.999965"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.986714"
                }
            ],
            "overall_sentiment_score": 0.123567,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.323078",
                    "ticker_sentiment_score": "0.218553",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "This Club pharmaceuticals name is set to soar in 2024",
            "url": "https://www.cnbc.com/2023/09/07/this-club-pharmaceuticals-name-is-set-to-soar-in-2024-.html",
            "time_published": "20230907T152108",
            "authors": [
                "Jeff Marks"
            ],
            "summary": "The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.",
            "banner_image": "https://image.cnbcfm.com/api/v1/image/107297080-16940973531694097347-31093328754-1080pnbcnews.jpg?v=1694099441&w=600&h=300&vtcrop=y",
            "source": "CNBC",
            "category_within_source": "Top News",
            "source_domain": "www.cnbc.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.967645"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.116098,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.421485",
                    "ticker_sentiment_score": "0.138809",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.625937",
                    "ticker_sentiment_score": "0.175253",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.175859",
                    "ticker_sentiment_score": "0.071165",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Should Franklin U.S. Large Cap Multifactor Index ETF  ( FLQL )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2145169/should-franklin-us-large-cap-multifactor-index-etf-flql-be-on-your-investing-radar",
            "time_published": "20230906T102006",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default311.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.162022,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.121959",
                    "ticker_sentiment_score": "0.062526",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MSFT",
                    "relevance_score": "0.121959",
                    "ticker_sentiment_score": "0.062526",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AAPL",
                    "relevance_score": "0.121959",
                    "ticker_sentiment_score": "0.062526",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Novo Nordisk  ( NVO )  Launches Wegovy in UK Amid Supply Issues",
            "url": "https://www.zacks.com/stock/news/2145039/novo-nordisk-nvo-launches-wegovy-in-uk-amid-supply-issues",
            "time_published": "20230905T175200",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Novo Nordisk (NVO) announces the controlled and limited launch of Wegovy in the U.K. amid rising demand for weight loss treatment and supply constraints.",
            "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.576289"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.203008,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "0.075687",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "DVAX",
                    "relevance_score": "0.089965",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVO",
                    "relevance_score": "0.465709",
                    "ticker_sentiment_score": "0.358427",
                    "ticker_sentiment_label": "Bullish"
                },
                {
                    "ticker": "PFE",
                    "relevance_score": "0.17879",
                    "ticker_sentiment_score": "0.076714",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "LLY: 3 Pharma Stocks Smart Money Is Following in September",
            "url": "https://stocknews.com/news/lly-zts-taro-sgtx-3-pharma-stocks-smart-money-is-following-in-september/",
            "time_published": "20230905T174052",
            "authors": [
                "StockNews.com Staff"
            ],
            "summary": "The pharmaceutical sector is poised for sustained expansion in the foreseeable future, propelled by factors such as the aging demographic, growing chronic illnesses, and technological advancements.",
            "banner_image": "https://stocknews.com/wp-content/uploads/2022/07/shutterstock_1110645284.jpg",
            "source": "Stocknews.com",
            "category_within_source": "n/a",
            "source_domain": "stocknews.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.54554"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.333333"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.333333"
                }
            ],
            "overall_sentiment_score": 0.217128,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.308891",
                    "ticker_sentiment_score": "-0.023044",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZTS",
                    "relevance_score": "0.28432",
                    "ticker_sentiment_score": "0.2611",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.125623",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "TARO",
                    "relevance_score": "0.131499",
                    "ticker_sentiment_score": "0.017201",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SGTX",
                    "relevance_score": "0.052801",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity For September 05 - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/09/34239112/eli-lilly-unusual-options-activity-for-september-05",
            "time_published": "20230905T144611",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Someone with a lot of money to spend has taken a bearish stance on Eli Lilly LLY. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.266143"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.132384,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GS",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.784902",
                    "ticker_sentiment_score": "0.172799",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "WFC",
                    "relevance_score": "0.098659",
                    "ticker_sentiment_score": "-0.122943",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Competing in These 3 Markets Could Send Eli Lilly Stock Soaring",
            "url": "https://www.fool.com/investing/2023/09/05/competing-in-these-3-markets-could-send-eli-lilly/",
            "time_published": "20230905T140000",
            "authors": [
                "Alex Carchidi"
            ],
            "summary": "Each market presents the opportunity for multiple catalysts as well as more sales.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.045819,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "GLDAF",
                    "relevance_score": "0.053749",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.455978",
                    "ticker_sentiment_score": "0.10002",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "BIIB",
                    "relevance_score": "0.053749",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Here's 1 Stock That Could Join Apple and Amazon in the $1 Trillion Club That You Might Have Overlooked",
            "url": "https://www.fool.com/investing/2023/09/05/heres-1-stock-that-could-join-apple-and-amazon-in/",
            "time_published": "20230905T131211",
            "authors": [
                "Keith Speights"
            ],
            "summary": "Hint: It isn't Tesla.",
            "banner_image": "https://g.foolcdn.com/misc-assets/hp-sa-cumulative-growth-chart.png",
            "source": "Motley Fool",
            "category_within_source": "n/a",
            "source_domain": "www.fool.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.260605,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.683932",
                    "ticker_sentiment_score": "0.338005",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "META",
                    "relevance_score": "0.122581",
                    "ticker_sentiment_score": "0.160349",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "MORN",
                    "relevance_score": "0.061473",
                    "ticker_sentiment_score": "0.187102",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "TSLA",
                    "relevance_score": "0.122581",
                    "ticker_sentiment_score": "0.188308",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "BRK-A",
                    "relevance_score": "0.061473",
                    "ticker_sentiment_score": "0.14004",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": " ( LLY )  - Analyzing Eli Lilly's Short Interest - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/short-sellers/23/09/34210640/lly-analyzing-eli-lillys-short-interest",
            "time_published": "20230904T140026",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly's LLY short percent of float has risen 8.33% since its last report. The company recently reported that it has 5.19 million shares sold short, which is 0.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.27 days to cover their ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Trading",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.365926"
                }
            ],
            "overall_sentiment_score": 0.265104,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.221819",
                    "ticker_sentiment_score": "0.15378",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "Here's How Much $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth Today - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/news/earnings/23/09/34184625/heres-how-much-1000-invested-in-eli-lilly-20-years-ago-would-be-worth-today",
            "time_published": "20230901T210022",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "Eli Lilly LLY has outperformed the market over the past 20 years by 3.99% on an annualized basis producing an average annual return of 11.65%. Currently, Eli Lilly has a market capitalization of $528.86 billion.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "News",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.108179"
                }
            ],
            "overall_sentiment_score": 0.158543,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.980595",
                    "ticker_sentiment_score": "0.375984",
                    "ticker_sentiment_label": "Bullish"
                }
            ]
        },
        {
            "title": "Should Invesco S&P 100 Equal Weight ETF  ( EQWL )  Be on Your Investing Radar?",
            "url": "https://www.zacks.com/stock/news/2143386/should-invesco-sp-100-equal-weight-etf-eqwl-be-on-your-investing-radar",
            "time_published": "20230901T102007",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Style Box ETF report for ...",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default354.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.147813,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.063265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.063265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CHTR",
                    "relevance_score": "0.130217",
                    "ticker_sentiment_score": "0.063265",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "IVZ",
                    "relevance_score": "0.194242",
                    "ticker_sentiment_score": "0.065428",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects - AbCellera Biologics  ( NASDAQ:ABCL ) ",
            "url": "https://www.benzinga.com/analyst-ratings/analyst-color/23/08/34153752/why-abcellera-biologics-is-still-a-buy-despite-dropping-royalties-analyst-on-long-t",
            "time_published": "20230831T191855",
            "authors": [
                "Nabaparna Bhattacharya"
            ],
            "summary": "Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. ABCL, lowering the price target to $12 on reduced valuations for other drug discovery stocks.",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/31/abcl.png?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "General",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.360215"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.161647"
                }
            ],
            "overall_sentiment_score": 0.026109,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "ABCL",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "-0.133584",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.451494",
                    "ticker_sentiment_score": "-0.0361",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Why Is Incyte  ( INCY )  Down 0.7% Since Last Earnings Report?",
            "url": "https://www.zacks.com/stock/news/2143111/why-is-incyte-incy-down-07-since-last-earnings-report",
            "time_published": "20230831T153128",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default332.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "0.976671"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.413559"
                }
            ],
            "overall_sentiment_score": 0.149755,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "BMRN",
                    "relevance_score": "0.039679",
                    "ticker_sentiment_score": "0.057849",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.079261",
                    "ticker_sentiment_score": "0.126034",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "INCY",
                    "relevance_score": "0.482217",
                    "ticker_sentiment_score": "0.221574",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                },
                {
                    "ticker": "REPL",
                    "relevance_score": "0.079261",
                    "ticker_sentiment_score": "0.141818",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly Unusual Options Activity For August 31 - Eli Lilly  ( NYSE:LLY ) ",
            "url": "https://www.benzinga.com/markets/options/23/08/34146280/eli-lilly-unusual-options-activity-for-august-31",
            "time_published": "20230831T143149",
            "authors": [
                "Benzinga Insights"
            ],
            "summary": "A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly LLY we detected 10 strange trades. If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish ...",
            "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop",
            "source": "Benzinga",
            "category_within_source": "Markets",
            "source_domain": "www.benzinga.com",
            "topics": [
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.5"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.214378"
                },
                {
                    "topic": "Earnings",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.5"
                }
            ],
            "overall_sentiment_score": 0.054682,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.871674",
                    "ticker_sentiment_score": "0.103251",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "GS",
                    "relevance_score": "0.109956",
                    "ticker_sentiment_score": "0.0",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "JPM",
                    "relevance_score": "0.109956",
                    "ticker_sentiment_score": "-0.127126",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "MS",
                    "relevance_score": "0.109956",
                    "ticker_sentiment_score": "-0.127126",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Eli Lilly and Company  ( LLY )  Is a Trending Stock: Facts to Know Before Betting on It",
            "url": "https://www.zacks.com/stock/news/2142870/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it",
            "time_published": "20230831T130011",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default311.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Earnings",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.503496"
                }
            ],
            "overall_sentiment_score": 0.224118,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.529767",
                    "ticker_sentiment_score": "0.154338",
                    "ticker_sentiment_label": "Somewhat-Bullish"
                }
            ]
        },
        {
            "title": "8 Stocks Turn $10,000 Into $120,005 In 8 Months",
            "url": "https://www.investors.com/etfs-and-funds/sectors/sp500-8-stocks-turn-10000-into-more-in-8-months-2023/",
            "time_published": "20230831T120000",
            "authors": [
                "Investor's Business Daily",
                "MATT KRANTZ"
            ],
            "summary": "Some investors might be satisfied with a 5% risk-free return. But those who pick the right S&P 500 stocks are doing much better than that.",
            "banner_image": "https://www.investors.com/wp-content/uploads/2023/01/Stock-moneyflood-01-shutt.jpg",
            "source": "Investors Business Daily",
            "category_within_source": "n/a",
            "source_domain": "www.investors.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Financial Markets",
                    "relevance_score": "0.87644"
                },
                {
                    "topic": "Manufacturing",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Technology",
                    "relevance_score": "0.25"
                },
                {
                    "topic": "Finance",
                    "relevance_score": "0.25"
                }
            ],
            "overall_sentiment_score": 0.20945,
            "overall_sentiment_label": "Somewhat-Bullish",
            "ticker_sentiment": [
                {
                    "ticker": "NVDA",
                    "relevance_score": "0.112269",
                    "ticker_sentiment_score": "0.083665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ANET",
                    "relevance_score": "0.167709",
                    "ticker_sentiment_score": "0.103993",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "CTLT",
                    "relevance_score": "0.112269",
                    "ticker_sentiment_score": "0.083665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AKAM",
                    "relevance_score": "0.112269",
                    "ticker_sentiment_score": "0.083665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "LLY",
                    "relevance_score": "0.112269",
                    "ticker_sentiment_score": "0.083665",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "ZIONL",
                    "relevance_score": "0.056275",
                    "ticker_sentiment_score": "0.074023",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "SPGI",
                    "relevance_score": "0.056275",
                    "ticker_sentiment_score": "0.063906",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        },
        {
            "title": "Medicare's First Price Negotiation List Targets Expensive Drugs  ( Revised ) ",
            "url": "https://www.zacks.com/stock/news/2142728/medicares-first-price-negotiation-list-targets-expensive-drugs-revised",
            "time_published": "20230831T065300",
            "authors": [
                "Zacks Equity Research"
            ],
            "summary": "The negotiations with participating drug companies are likely to happen in 2023 and 2024 with the negotiated prices, if any, going into effect in 2026.",
            "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default145.jpg",
            "source": "Zacks Commentary",
            "category_within_source": "n/a",
            "source_domain": "www.zacks.com",
            "topics": [
                {
                    "topic": "Economy - Monetary",
                    "relevance_score": "0.158519"
                },
                {
                    "topic": "Life Sciences",
                    "relevance_score": "1.0"
                }
            ],
            "overall_sentiment_score": 0.021558,
            "overall_sentiment_label": "Neutral",
            "ticker_sentiment": [
                {
                    "ticker": "LLY",
                    "relevance_score": "0.200688",
                    "ticker_sentiment_score": "-0.011416",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AMGN",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "-0.008722",
                    "ticker_sentiment_label": "Neutral"
                },
                {
                    "ticker": "AZN",
                    "relevance_score": "0.13459",
                    "ticker_sentiment_score": "-0.077816",
                    "ticker_sentiment_label": "Neutral"
                }
            ]
        }
    ]
}